Celon Pharma S.A. is the leader of the Forbes TOP25 of Tech-Medical Industry Ranking

Celon Pharma S.A. has become the leader of the ranking prepared by Forbes magazine.

It is the largest, and, more importantly, the most mature biopharmaceutical company developing its own drugs – as justified by the authors of the report, who also underline the Company's broadest and most advanced portfolio of innovative drugs among Polish biotech companies, as well as profitability and stable portfolio of generic drugs. The whole ranking is available on the Forbes website